Tasca Therapeutics
MA - BostonBiotechnology
Focus: Identifies and maps novel lipid-binding pockets on proteins to develop new medicines
Tasca Therapeutics is a life sciences company focused on Identifies and maps novel lipid-binding pockets on proteins to develop new medicines.
Profile data last refreshed Yesterday
Funding Stage
SERIES A
Open Jobs
0
Data completeness
1/9 — Limited
Company HealthSolid
Pipeline
Early-stage
1 total
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
CP-383
Solid Tumor MalignanciesClinical Trials (1)
NCT07030257Study of CP-383 in Patients With Advanced or Metastatic Solid Tumors
Phase 1/2Help build intelligence for Tasca Therapeutics
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.